• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一类新型强效和高选择性的内吗啡肽-1 类似物,包含α-亚甲基-β-氨基丙酸(map)。

A new class of highly potent and selective endomorphin-1 analogues containing α-methylene-β-aminopropanoic acids (map).

机构信息

Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Institute of Biochemistry and Molecular Biology, School of Life Sciences, Lanzhou University, Lanzhou, 730000, P. R. China.

出版信息

J Med Chem. 2012 Jul 12;55(13):6224-36. doi: 10.1021/jm300664y. Epub 2012 Jul 2.

DOI:10.1021/jm300664y
PMID:22724433
Abstract

A new class of endomorphin-1 (EM-1) analogues were synthesized by introduction of novel unnatural α-methylene-β-amino acids (Map) at position 3 or/and position 4. Their binding and functional activity, metabolic stability, and antinociceptive activity were determined and compared. Most of these analogues showed high affinities for the μ-opioid receptor and an increased stability in mouse brain homogenates compared with EM-1. Examination of cAMP accumulation and ERK1/2 phosphorylation in HEK293 cells confirmed the agonist properties of these analogues. Among these new analogues, H-Tyr-Pro-Trp-(2-furyl)Map-NH(2) (analogue 12) exhibited the highest binding potency (K(i)(μ) = 0.221 nM) and efficacy (EC(50) = 0.0334 nM, E(max) = 97.14%). This analogue also displayed enhanced antinociceptive activity in vivo in comparison to EM-1. Molecular modeling approaches were then carried out to demonstrate the interaction pattern of these analogues with the opioid receptors. We found that, compared to EM-1, the incorporation of our synthesized Map at position 4 would bring the analogue to a closer binding mode with the μ-opioid receptor.

摘要

研究人员通过在第 3 位或/和第 4 位引入新型非天然的α-亚甲基-β-氨基酸(Map),合成了一类新型内吗啡肽-1(EM-1)类似物。测定并比较了这些类似物的结合和功能活性、代谢稳定性和镇痛活性。与 EM-1 相比,这些类似物中的大多数对μ-阿片受体具有高亲和力,并且在小鼠脑匀浆中的稳定性增加。在 HEK293 细胞中检测 cAMP 积累和 ERK1/2 磷酸化证实了这些类似物的激动剂特性。在这些新类似物中,H-Tyr-Pro-Trp-(2-呋喃基)Map-NH(2)(类似物 12)表现出最高的结合效力(K(i)(μ) = 0.221 nM)和功效(EC(50) = 0.0334 nM,E(max) = 97.14%)。与 EM-1 相比,该类似物在体内也表现出增强的镇痛活性。然后进行了分子建模方法,以证明这些类似物与阿片受体的相互作用模式。我们发现,与 EM-1 相比,我们合成的 Map 位于 4 位会使类似物与μ-阿片受体的结合模式更加接近。

相似文献

1
A new class of highly potent and selective endomorphin-1 analogues containing α-methylene-β-aminopropanoic acids (map).一类新型强效和高选择性的内吗啡肽-1 类似物,包含α-亚甲基-β-氨基丙酸(map)。
J Med Chem. 2012 Jul 12;55(13):6224-36. doi: 10.1021/jm300664y. Epub 2012 Jul 2.
2
Design, synthesis, and pharmacological characterization of novel endomorphin-1 analogues as extremely potent μ-opioid agonists.新型内吗啡肽-1 类似物的设计、合成与药理学特性研究作为极高效 μ 阿片受体激动剂。
J Med Chem. 2013 Apr 11;56(7):3102-14. doi: 10.1021/jm400195y. Epub 2013 Mar 28.
3
Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).强效和选择性μ-阿片受体拮抗剂[Dmt(1), D-2-Nal(4)]内吗啡肽-1(Antanal-1)和[Dmt(1), D-2-Nal(4)]内吗啡肽-2(Antanal-2)的合成与表征
J Med Chem. 2007 Feb 8;50(3):512-20. doi: 10.1021/jm060998u.
4
Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties.具有混合μ/δ阿片受体激动剂和δ阿片受体拮抗剂特性的强效双功能内吗啡肽-2类似物的研发。
J Med Chem. 2004 Jul 1;47(14):3591-9. doi: 10.1021/jm030649p.
5
Superpotent [Dmt¹] dermorphin tetrapeptides containing the 4-aminotetrahydro-2-benzazepin-3-one scaffold with mixed μ/δ opioid receptor agonistic properties.具有混合 μ/δ 阿片受体激动特性的含 4-氨基四氢-2-苯并氮杂卓-3-酮支架的超强效 [Dmt¹] 二氨吗啡烷四肽。
J Med Chem. 2011 Nov 24;54(22):7848-59. doi: 10.1021/jm200894e. Epub 2011 Oct 20.
6
Opioid profiles of Cys2-containing enkephalin analogues.含半胱氨酸2的脑啡肽类似物的阿片样物质特性
Eur J Pharmacol. 2004 Sep 13;498(1-3):249-56. doi: 10.1016/j.ejphar.2004.07.059.
7
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.纳曲酮衍生的吡啶并和嘧啶并吗啡喃的合成、阿片受体结合及生物活性
J Med Chem. 1999 Sep 9;42(18):3527-38. doi: 10.1021/jm990039i.
8
Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.δ-阿片受体拮抗剂TIPP中的侧链甲基取代对活性特征有重要影响。
J Med Chem. 1998 Dec 17;41(26):5167-76. doi: 10.1021/jm981011u.
9
Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2.利用内吗啡肽-2独特的酪氨酸类似物开发强效μ-阿片受体配体。
J Med Chem. 2005 Jan 27;48(2):586-92. doi: 10.1021/jm049384k.
10
Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].在源自纳洛酮、羟吗啡酮和氢吗啡酮[纠正为氢吗啡酮]的吡啶吗啡喃类化合物中鉴定具有混合μ激动剂/δ拮抗剂活性的阿片样物质配体。
J Med Chem. 2004 Mar 11;47(6):1400-12. doi: 10.1021/jm030311v.

引用本文的文献

1
Therapeutic peptides: chemical strategies fortify peptides for enhanced disease treatment efficacy.治疗性肽:强化肽以提高疾病治疗效果的化学策略。
Amino Acids. 2025 May 8;57(1):25. doi: 10.1007/s00726-025-03454-5.
2
The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder.内源性阿片肽的前世今生:对其合成、时空动态的最新认识及其在酒精使用障碍中的临床影响。
Neuropharmacology. 2023 Mar 1;225:109376. doi: 10.1016/j.neuropharm.2022.109376. Epub 2022 Dec 11.
3
Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery.
肽模拟物及其在阿片肽药物发现中的应用。
Biomolecules. 2022 Sep 5;12(9):1241. doi: 10.3390/biom12091241.
4
Polyhydroxylated Cyclopentane β-Amino Acids Derived from d-Mannose and d-Galactose: Synthesis and Protocol for Incorporation into Peptides.源自d-甘露糖和d-半乳糖的多羟基化环戊烷β-氨基酸:合成及掺入肽的方案
ACS Omega. 2022 Jan 4;7(2):2002-2014. doi: 10.1021/acsomega.1c05468. eCollection 2022 Jan 18.
5
β--Amino Acid Scan of µ-Selective Opioid Tetrapeptide TAPP.µ 型选择性阿片四肽 TAPP 的β-氨基酸扫描。
Molecules. 2020 May 25;25(10):2461. doi: 10.3390/molecules25102461.
6
BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.BN-9是一种具有混合阿片样物质和神经肽FF受体激动特性的嵌合肽,可在小鼠中产生不形成耐受性的镇痛作用。
Br J Pharmacol. 2016 Jun;173(11):1864-80. doi: 10.1111/bph.13489. Epub 2016 Apr 21.